EcoDrugPlus

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSLACG00000000280
Gene Symbol: WEE1
4 Cross references
226 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSLACG00000016474
Gene Symbol: YES1
4 Cross references
269 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSLACG00000012052
Gene Symbol: ACVR2B
3 Cross references
257 Possible Orthologues:

Adenosine A1 Receptor

Ensembl ID : ENSLACG00000014019
Gene Symbol: ADORA1
4 Cross references
273 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSLACG00000015554
Gene Symbol: ADORA2A
4 Cross references
260 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSLACG00000003295
Gene Symbol: ADORA2B
4 Cross references
199 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSLACG00000008232
Gene Symbol: ADA
1 Cross references
6 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSLACG00000014776
Gene Symbol: ADA
4 Cross references
216 Possible Orthologues:

Adrenoceptor Alpha 1a

Ensembl ID : ENSLACG00000001634
Gene Symbol: ADRA1A
4 Cross references
202 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSLACG00000012511
Gene Symbol: ADRA1B
2 Cross references
263 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSLACG00000002533
Gene Symbol: ADRA1D
4 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSLACG00000008037
Gene Symbol: ADRA2B
3 Cross references
219 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).